Korean J Urol.
1986 Feb;27(1):191-194.
Two Cases of Advanced Bladder Carcinoma, Treated with CISCA Regimen
- Affiliations
-
- 1Department of Urology, Yonsei University College of Medicine, Seoul, Korea.
Abstract
- The CISCA regimen (Cis-platinum, Cyclophosphamide and Adriamycin combination), first reported by Sternberg et al. at 1977 is most excellent combination chemotherapy regimen for treatment of advanced bladder carcinoma other than single or combination chemotherapy regimen ever reported and its overall response rate was average 46%. We experienced two cases of advanced bladder carcinoma, treated with CISCA regimen, followed by radiotherapy and/or cystectomy. All 3 drugs (70mg/m2 Cis-platinum in five divided dose, 400mg/m2 Cyclophosphamide and 40mg/m2 Adriamycin) were given as a single dose every 1 weeks. During enforcement of each 3 and 2 cycles, the definite symptomatic relief was observed. The complications were minimal and were relatively well tolerated by patients. The chemotherapy of transitional cell carcinoma of the bladder with CISCA regimen appears to be effective.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- CISCA Combination Chemotherapy in Advanced Bladder Cancer
- A Retrospective Study Comparing M-VAC and CISCA Chemotherapy in Advanced Urothelial Transitional Cell Carcinoma
- M-VAC Combination Chemotherapy in Advanced Bladder Cancer
- M-VAC Monotherapy for Advanced Transitional Cell Carcinoma of the Bladder
- A Clinical Observation of the Intravesical Thiotepa in Bladder Cancer
